The Novel Innovations for Tissue Regeneration in Osteoarthritis will explore ways to help the human body repair its own joints, according to a May 18 news release. Under the program, NITRO will explore technologies in three areas: injectable bone regeneration, injectable cartilage regeneration and replacement joints made from human cells.
The program is the first program under the ARPA-H.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
